Immunomic Therapeutics, Inc.

Amendment
CIK: 0001543256·Biotechnology·DELAWARE·Filed: Oct 15, 2014
Total Offering

$8,800,000

Amount Sold

$6,755,052

Investors

56

First Sale

Dec 28, 2013

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
William G Hearl
Related Person
Bernard C Rudnick
Related Person
Bruce F. Mackler
Related Person
Michael D. Lack
Related Person
James Wishart
Related Person
Ronald Thiboutot
Related Person
William Barry McDonald
Related Person
Teri Jones Heiland
Related Person

Company

Immunomic Therapeutics, Inc.

ATTN: WILLIAM HEARL, 313 W. LIBERTY ST.

LANCASTER, PA, 17603

717-327-1919

SEC Filing

0001543256-14-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Immunomic Therapeutics, Inc. Form D Filing — $8,800,000 | FilingFlow